Fabrizio Montecucco Selected Research

Infarction (Infarctions)

1/2020	Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3.
1/2020	Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update.
1/2019	Impact of Red Wine Consumption on Cardiovascular Health.
1/2019	HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3.
10/2018	Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke.
12/2017	4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability.
6/2016	Cellular recruitment in myocardial ischaemia/reperfusion injury.
4/2016	Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
3/2016	Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
1/2016	Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizio Montecucco Research Topics

Disease

56	Atherosclerosis 02/2022 - 01/2008
44	Inflammation (Inflammations) 12/2021 - 06/2006
41	Atherosclerotic Plaque (Atheroma) 02/2022 - 12/2006
27	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 01/2009
23	Myocardial Infarction 07/2021 - 02/2011
20	Ischemic Stroke 07/2021 - 07/2010
17	Infarction (Infarctions) 01/2020 - 05/2009
15	Stroke (Strokes) 12/2021 - 01/2012
14	Thrombosis (Thrombus) 01/2022 - 01/2012
13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2008
12	Obesity 04/2022 - 01/2008
12	Insulin Resistance 02/2021 - 01/2008
11	Acute Coronary Syndrome 01/2021 - 04/2013
11	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 02/2011
10	Neoplasms (Cancer) 08/2021 - 01/2008
9	Carotid Artery Diseases 02/2022 - 04/2013
9	Hypertension (High Blood Pressure) 01/2022 - 01/2008
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2006
7	Ischemia 01/2020 - 05/2009
7	Necrosis 10/2018 - 05/2011
6	Rupture 02/2022 - 01/2007
6	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2008
6	Reperfusion Injury 01/2019 - 11/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2017
6	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2007
5	Coronary Disease (Coronary Heart Disease) 01/2022 - 11/2013
5	Hemorrhage 01/2022 - 01/2015
5	Metabolic Diseases (Metabolic Disease) 02/2021 - 01/2015
5	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2008
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020 - 01/2017
5	Heart Failure 02/2019 - 08/2012
5	Pathologic Constriction (Stenosis) 12/2018 - 08/2012
4	Hypercholesterolemia 01/2022 - 10/2013
4	Chronic Disease (Chronic Diseases) 01/2021 - 01/2009
4	Diabetes Complications 01/2021 - 01/2013
4	Sepsis (Septicemia) 10/2020 - 01/2018
4	Hyperglycemia 05/2018 - 01/2013
4	Myocardial Reperfusion Injury 04/2016 - 08/2009
4	Erectile Dysfunction 02/2015 - 01/2013
3	Pulmonary Embolism 01/2022 - 12/2012
3	Diabetes Mellitus 01/2021 - 05/2018
3	Infections 01/2021 - 05/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 05/2019
3	Septic Shock (Toxic Shock Syndrome) 10/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
22	LipidsIBA 12/2021 - 01/2008
20	ChemokinesIBA 01/2022 - 01/2008
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 06/2009
17	CytokinesIBA 01/2021 - 01/2007
16	Immunoglobulin G (IgG)IBA 10/2020 - 07/2007
14	Apolipoproteins E (ApoE)IBA 02/2022 - 02/2011
14	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 09/2010
10	AdipokinesIBA 08/2021 - 07/2013
10	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 01/2008
10	EndocannabinoidsIBA 10/2016 - 01/2009
9	AutoantibodiesIBA 10/2020 - 01/2015
9	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 07/2010
8	CholesterolIBA 02/2022 - 08/2015
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
8	LeptinIBA 01/2021 - 06/2006
8	CollagenIBA 10/2020 - 01/2013
8	C-Reactive ProteinIBA 11/2019 - 12/2012
7	RNA (Ribonucleic Acid)IBA 02/2022 - 07/2015
7	OsteopontinIBA 01/2022 - 06/2015
7	Matrix Metalloproteinases (MMPs)IBA 11/2021 - 03/2012
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
7	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2007
6	Insulin (Novolin)FDA Link 01/2021 - 12/2006
6	Oxidants (Oxidizing Agents)IBA 01/2019 - 12/2008
6	Nicotinamide PhosphoribosyltransferaseIBA 12/2016 - 01/2013
6	CXC ChemokinesIBA 10/2014 - 07/2010
5	AdiponectinIBA 04/2022 - 01/2017
5	ApolipoproteinsIBA 02/2022 - 01/2012
5	InflammasomesIBA 12/2021 - 01/2019
5	LDL CholesterolIBA 12/2020 - 01/2018
5	ResistinIBA 10/2020 - 12/2012
5	AntibodiesIBA 01/2020 - 02/2011
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2013
5	CannabinoidsIBA 01/2018 - 01/2009
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2015 - 01/2009
5	EnzymesIBA 12/2014 - 12/2009
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2014 - 05/2009
4	LigandsIBA 01/2022 - 01/2007
4	Protein Isoforms (Isoforms)IBA 02/2020 - 01/2007
4	Lipoproteins (Lipoprotein)IBA 01/2020 - 03/2016
4	Troponin IIBA 03/2016 - 05/2009
4	AngiotensinsIBA 11/2015 - 01/2009
4	angiotensin I (1-7)IBA 02/2015 - 12/2012
4	Hormones (Hormone)IBA 01/2013 - 01/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022 - 06/2016
3	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 12/2014
3	Colchicine FDA LinkGeneric 02/2021 - 01/2019
3	Therapeutic UsesIBA 01/2021 - 12/2011
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 04/2013
3	oxidized low density lipoproteinIBA 01/2020 - 09/2010

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2009
4	Bariatric Surgery 02/2021 - 10/2017
4	Glycemic Control 01/2021 - 09/2015
4	Endarterectomy (Thromboendarterectomy) 01/2021 - 10/2016
3	Carotid Endarterectomy 10/2020 - 01/2018